IL128573A0 - Treatment of upper airway allergic responses with a combination of histamine receptor antagonists - Google Patents

Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Info

Publication number
IL128573A0
IL128573A0 IL12857397A IL12857397A IL128573A0 IL 128573 A0 IL128573 A0 IL 128573A0 IL 12857397 A IL12857397 A IL 12857397A IL 12857397 A IL12857397 A IL 12857397A IL 128573 A0 IL128573 A0 IL 128573A0
Authority
IL
Israel
Prior art keywords
treatment
combination
receptor antagonists
upper airway
histamine receptor
Prior art date
Application number
IL12857397A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL128573A0 publication Critical patent/IL128573A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL12857397A 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists IL128573A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (1)

Publication Number Publication Date
IL128573A0 true IL128573A0 (en) 2000-01-31

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12857397A IL128573A0 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Country Status (25)

Country Link
EP (1) EP0920315B1 (pl)
JP (2) JP3638289B2 (pl)
KR (1) KR20000029975A (pl)
CN (1) CN1152682C (pl)
AR (1) AR008293A1 (pl)
AT (1) ATE314071T1 (pl)
AU (1) AU722040B2 (pl)
BR (1) BR9711149A (pl)
CA (1) CA2263163A1 (pl)
CO (1) CO4910138A1 (pl)
CZ (1) CZ43299A3 (pl)
DE (1) DE69734984D1 (pl)
HU (1) HUP9904362A3 (pl)
ID (1) ID17871A (pl)
IL (1) IL128573A0 (pl)
MY (1) MY116130A (pl)
NO (1) NO990706L (pl)
NZ (1) NZ334063A (pl)
PE (1) PE100298A1 (pl)
PL (1) PL191073B1 (pl)
SK (1) SK20099A3 (pl)
TR (1) TR199900326T2 (pl)
TW (2) TW200427450A (pl)
WO (1) WO1998006394A1 (pl)
ZA (1) ZA977263B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527200A (en) * 1997-03-26 2004-12-24 Sepracor Inc Stable norastemizole formulations including a super disintegrant
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
DE69811110T2 (de) * 1997-11-07 2003-11-27 Schering Corp., Kenilworth Phenyl-alkyl imidazole als h3 rezeptor antagonisten
IL135727A0 (en) * 1997-11-07 2001-05-20 Schering Corp Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
KR20010031724A (ko) * 1997-11-07 2001-04-16 둘락 노먼 씨. 페닐-알킬-이미다졸 유형의 ｈ₃ 수용체 리간드
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
WO2000021512A2 (en) * 1998-10-09 2000-04-20 Schering Corporation Composition and method for treating allergic diseases
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
JP2003509459A (ja) * 1999-09-22 2003-03-11 シェーリング コーポレイション アレルギー状態および炎症状態の処置
NZ519797A (en) * 2000-02-03 2005-05-27 Schering Corp Treating allergic and inflammatory conditions
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
MY131890A (en) 2001-03-13 2007-09-28 Schering Corp Piperidine compounds
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
CN100360130C (zh) 2002-04-18 2008-01-09 先灵公司 用作组胺h3拮抗剂的1－(4－哌啶基)苯并咪唑酮
IL165863A0 (en) 2002-06-24 2006-01-15 Schering Corp Indole derivatives useful as histamine H3 antagonists
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
ATE450526T1 (de) 2005-06-20 2009-12-15 Schering Corp Als antagonisten von histamin h3 geeignete piperidinderivate
US20110166124A1 (en) 2008-07-23 2011-07-07 Mccormick Kevin D Tricyclic spirocycle derivatives and methods of use
JP2012505899A (ja) 2008-10-16 2012-03-08 シェーリング コーポレイション アジン誘導体およびそれの使用方法
EP2379564A1 (en) 2008-12-19 2011-10-26 Schering Corporation Bicyclic heterocyclic derivatives and methods of use thereof
US20110245267A1 (en) 2008-12-19 2011-10-06 Schering Plough Corporation Piperidine and piperazine derivatives and methods of use thereof
PT3943069T (pt) 2009-03-17 2025-02-21 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
CN102573847A (zh) * 2009-05-14 2012-07-11 总医院公司 治疗退化性及缺血性疾病的方法和组合物
WO2011043994A1 (en) 2009-10-08 2011-04-14 Schering Corporation Inhibitors of fatty acid binding protein (fabp)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
KR20000029975A (ko) 2000-05-25
PL331617A1 (en) 1999-08-02
NO990706D0 (no) 1999-02-15
JP3638289B2 (ja) 2005-04-13
TW200427450A (en) 2004-12-16
JP2003095979A (ja) 2003-04-03
WO1998006394A1 (en) 1998-02-19
AR008293A1 (es) 1999-12-29
EP0920315A1 (en) 1999-06-09
JP2000505094A (ja) 2000-04-25
HUP9904362A2 (hu) 2000-11-28
NZ334063A (en) 2000-09-29
EP0920315B1 (en) 2005-12-28
NO990706L (no) 1999-02-15
HUP9904362A3 (en) 2000-12-28
CZ43299A3 (cs) 1999-07-14
CO4910138A1 (es) 2000-04-24
AU3973397A (en) 1998-03-06
ZA977263B (en) 1998-02-16
CN1152682C (zh) 2004-06-09
BR9711149A (pt) 1999-08-17
ATE314071T1 (de) 2006-01-15
AU722040B2 (en) 2000-07-20
PE100298A1 (es) 1999-01-11
SK20099A3 (en) 2000-08-14
TR199900326T2 (xx) 1999-05-21
ID17871A (id) 1998-02-05
DE69734984D1 (de) 2006-02-02
MY116130A (en) 2003-11-28
TWI221768B (en) 2004-10-11
CN1233179A (zh) 1999-10-27
CA2263163A1 (en) 1998-02-19
PL191073B1 (pl) 2006-03-31

Similar Documents

Publication Publication Date Title
IL128573A0 (en) Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
ZA9510431B (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
IL115613A0 (en) Bicyclic neuropeptide y receptor antagonists
PL311272A1 (en) Antagonists of endotheline receptors
IL122641A0 (en) Vitronectin receptor antagonists their preparation and their use
PL331539A1 (en) Antagonists of il-8 receptor
IL111379A0 (en) Histamine h3-receptor antagonists and therapeutic uses thereof
GB9905275D0 (en) Treatment of conditions associated with membrane-bound receptors and their function
PL328633A1 (en) Oxazolic and thiadizolic antagonists of muscarinic receptors
IL122643A0 (en) Vitronectin receptor antagonists their preparation and their use
PL310386A1 (en) Antagonists of factor i receptors
ZA959434B (en) Adhesion receptor antagonists
IL128631A0 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
ZA952461B (en) Antagonists of endothelin receptors
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
PL333023A1 (en) Chimerical antagonists of haeomogenic multifunctional receptors
ZA9510686B (en) Human somatostatin-like receptor
EP0711830A3 (en) Murine and human galanin receptor
AU1461892A (en) Use of sigma receptor antagonists for treatment of cocaine abuse
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
EP0747055A3 (en) Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis
PL320638A1 (en) Antagonists of endothein receptors
HU9602127D0 (en) Endotheline receptor antagonists
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
AU3116697A (en) Human interleukin-1j and antagonists thereof